Benitec Biopharma Ltd Stock Number Of Employees

BNTC Stock  USD 9.85  0.30  2.96%   
Benitec Biopharma Ltd fundamentals help investors to digest information that contributes to Benitec Biopharma's financial success or failures. It also enables traders to predict the movement of Benitec Stock. The fundamental analysis module provides a way to measure Benitec Biopharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Benitec Biopharma stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Benitec Biopharma Ltd Company Number Of Employees Analysis

Benitec Biopharma's Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.

Number of Employees

 = 

Full Time

+

Part Time

More About Number Of Employees | All Equity Analysis

Current Benitec Biopharma Number Of Employees

    
  16  
Most of Benitec Biopharma's fundamental indicators, such as Number Of Employees, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Benitec Biopharma Ltd is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Benitec Number Of Employees Driver Correlations

Understanding the fundamental principles of building solid financial models for Benitec Biopharma is extremely important. It helps to project a fair market value of Benitec Stock properly, considering its historical fundamentals such as Number Of Employees. Since Benitec Biopharma's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Benitec Biopharma's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Benitec Biopharma's interrelated accounts and indicators.
0.99-1.0-0.380.17-0.210.391.0-0.07-0.28-0.01-0.160.930.93-0.08-0.82
0.99-0.99-0.290.13-0.20.291.00.0-0.340.08-0.160.910.91-0.01-0.77
-1.0-0.990.36-0.170.24-0.37-1.00.080.270.00.19-0.92-0.920.090.8
-0.38-0.290.36-0.210.23-0.93-0.360.83-0.620.850.21-0.52-0.510.840.78
0.170.13-0.17-0.210.160.490.17-0.010.08-0.270.580.20.2-0.01-0.23
-0.21-0.20.240.230.16-0.15-0.20.47-0.030.070.78-0.07-0.070.450.17
0.390.29-0.37-0.930.49-0.150.37-0.680.52-0.83-0.040.50.49-0.68-0.77
1.01.0-1.0-0.360.17-0.20.37-0.05-0.290.01-0.160.930.93-0.06-0.81
-0.070.00.080.83-0.010.47-0.68-0.05-0.780.810.34-0.21-0.21.00.47
-0.28-0.340.27-0.620.08-0.030.52-0.29-0.78-0.870.04-0.01-0.02-0.77-0.23
-0.010.080.00.85-0.270.07-0.830.010.81-0.870.02-0.24-0.240.790.55
-0.16-0.160.190.210.580.78-0.04-0.160.340.040.02-0.07-0.070.330.16
0.930.91-0.92-0.520.2-0.070.50.93-0.21-0.01-0.24-0.071.0-0.21-0.91
0.930.91-0.92-0.510.2-0.070.490.93-0.2-0.02-0.24-0.071.0-0.2-0.91
-0.08-0.010.090.84-0.010.45-0.68-0.061.0-0.770.790.33-0.21-0.20.48
-0.82-0.770.80.78-0.230.17-0.77-0.810.47-0.230.550.16-0.91-0.910.48
Click cells to compare fundamentals
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
Competition

Based on the recorded statements, Benitec Biopharma Ltd is currently employing 16.0 people. This is 99.85% lower than that of the Biotechnology sector and 97.01% lower than that of the Health Care industry. The number of employees for all United States stocks is 99.92% higher than that of the company.

Benitec Number Of Employees Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Benitec Biopharma's direct or indirect competition against its Number Of Employees to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Benitec Biopharma could also be used in its relative valuation, which is a method of valuing Benitec Biopharma by comparing valuation metrics of similar companies.
Benitec Biopharma is currently under evaluation in number of employees category among its peers.

Benitec Biopharma Current Valuation Drivers

We derive many important indicators used in calculating different scores of Benitec Biopharma from analyzing Benitec Biopharma's financial statements. These drivers represent accounts that assess Benitec Biopharma's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Benitec Biopharma's important valuation drivers and their relationship over time.
201920202021202220232024 (projected)
Market Cap8.1M18.3M9.5M5.6M29.5M33.0M
Enterprise Value(1.3M)(1.3M)6.2M3.7M(21.1M)(20.0M)

Benitec Biopharma ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Benitec Biopharma's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Benitec Biopharma's managers, analysts, and investors.
Environmental
Governance
Social

Benitec Fundamentals

About Benitec Biopharma Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Benitec Biopharma Ltd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Benitec Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Benitec Biopharma Ltd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Benitec Biopharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Benitec Biopharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Benitec Biopharma Ltd Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Benitec Biopharma Ltd Stock:
Check out Benitec Biopharma Piotroski F Score and Benitec Biopharma Altman Z Score analysis.
You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Benitec Biopharma. If investors know Benitec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Benitec Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.51)
Revenue Per Share
0.003
Quarterly Revenue Growth
0.125
Return On Assets
(0.50)
Return On Equity
(0.92)
The market value of Benitec Biopharma is measured differently than its book value, which is the value of Benitec that is recorded on the company's balance sheet. Investors also form their own opinion of Benitec Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Benitec Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Benitec Biopharma's market value can be influenced by many factors that don't directly affect Benitec Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Benitec Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Benitec Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Benitec Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.